| WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for … M Shankar-Hari, CL Vale, PJ Godolphin, D Fisher, JPT Higgins, F Spiga, ... jama 326 (6), 499-518, 2021 | 505* | 2021 |
| IL-6 and other biomarkers as predictors of severity in COVID-19 N Broman, K Rantasärkkä, T Feuth, M Valtonen, M Waris, U Hohenthal, ... Annals of medicine 53 (1), 410-412, 2021 | 113 | 2021 |
| Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection T Feuth, JE Arends, JH Fransen, NM Nanlohy, KJ van Erpecum, ... PloS one 8 (3), e59302, 2013 | 83 | 2013 |
| Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide. M Feuth, JW Brandsma, WR Faber, B Bhattarai, T Feuth, AM Anderson | 41 | 2008 |
| Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study N Broman, T Feuth, T Vuorinen, M Valtonen, U Hohenthal, E Löyttyniemi, ... Clinical Microbiology and Infection 28 (6), 844-851, 2022 | 32 | 2022 |
| Is sleep apnea a risk factor for Covid-19? findings from a retrospective cohort study T Feuth, T Saaresranta, A Karlsson, M Valtonen, V Peltola, E Rintala, ... Sleep Medicine and Disorders: International Journal 4 (3), 61-65, 2020 | 23 | 2020 |
| CD4/CD8 ratio is a promising candidate for non-invasive measurement of liver fibrosis in chronic HCV-monoinfected patients T Feuth, D van Baarle, KJ van Erpecum, PD Siersema, AIM Hoepelman, ... European journal of clinical microbiology & infectious diseases 33, 1113-1117, 2014 | 18 | 2014 |
| Outbreak of invasive pneumococcal disease among shipyard workers, Turku, Finland, May to November 2019 M Linkevicius, V Cristea, L Siira, H Mäkelä, M Toropainen, M Pitkäpaasi, ... Eurosurveillance 24 (49), 1900681, 2019 | 15 | 2019 |
| The presence of protective cytotoxic T lymphocytes does not correlate with shorter lifespans of productively infected cells in HIV-1 infection HB Spits, T Mudrikova, IMM Schellens, AMJ Wensing, JM Prins, T Feuth, ... Aids 30 (1), 9-17, 2016 | 10 | 2016 |
| Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV–HCV coinfected patients, irrespective of liver disease severity T Feuth, D Van Baarle, AIM Hoepelman, KJ Van Erpecum, PD Siersema, ... Apoptosis 19, 1128-1135, 2014 | 10 | 2014 |
| Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines T Feuth, RL Patovirta, S Grierson, M Danilovits, P Viiklepp, HK Aaltonen, ... The International Journal of Tuberculosis and Lung Disease 25 (7), 554-559, 2021 | 7 | 2021 |
| Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis T Feuth, JE Arends, FI Lieveld, MW Mundt, AIM Hoepelman, PD Siersema, ... Scandinavian Journal of Gastroenterology 48 (9), 1074-1081, 2013 | 7 | 2013 |
| Lower respiratory tract infections among newly diagnosed sleep apnea patients J Keto, T Feuth, M Linna, T Saaresranta BMC Pulmonary Medicine 23 (1), 332, 2023 | 4 | 2023 |
| Association of human myxovirus resistance protein A with severity of COVID-19 O Lehtinen, N Broman, M Waris, T Vuorinen, V Peltola, E Löyttyniemi, ... BMC Infectious Diseases 22 (1), 755, 2022 | 4 | 2022 |
| Kafka is dood T Feuth Singel Uitgeverijen, 2020 | 2 | 2020 |
| Rapid implementation of home oxygen treatment and remote monitoring for COVID-19 patients at the verge of the Omicron wave in Turku, Finland J Hänninen, U Anttalainen, M Kilpeläinen, U Hohenthal, N Broman, ... BMC Infectious Diseases 23 (1), 799, 2023 | 1 | 2023 |
| ‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’–Author's reply N Broman, T Feuth, J Oksi Clinical Microbiology and Infection 28 (11), 1520-1521, 2022 | 1 | 2022 |
| Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy E Feuth, V Nieminen, A Palomäki, J Ranti, M Sucksdorff, T Finnilä, J Oksi, ... European Journal of Clinical Microbiology & Infectious Diseases 43 (4), 723-734, 2024 | | 2024 |
| Short-and long-term effects of imatinib in patients hospitalised for COVID-19 infection: A randomised controlled trial ALE Halme, S Laakkonen, J Rutanen, OPO Nevalainen, M Sinisalo, ... medRxiv, 2024.02. 02.24302227, 2024 | | 2024 |
| Tuberculosis in Kidney Transplant Recipients: A Nationwide Cohort in a Low Tuberculosis Incidence Country T Feuth, I Rajalahti, T Vasankari, M Gissler, R Rimhanen-Finne, P Finne, ... Transplantation Direct 9 (9), e1527, 2023 | | 2023 |
